Despite an abundance of available options, patients with migraine are often dissatisfied with current abortive therapies. Studies indicate that up to a third of patients do not respond to triptans used as first-line therapies, and many more switch therapies regularly because of adverse effects

Read more here.

Subscribe To Our Weekly Newsletter

Subscribe To Our Weekly Newsletter

Get a weekly digest of our posts straight to your inbox! We promise, no spam ever.

You have Successfully Subscribed!

Pin It on Pinterest